DIVIDEND ANNOUNCEMENT: Bristol Myers Squibb Co. (NYSE:BMY) on 03/03/2023 declared a dividend of $0.5700 per share

Bristol Myers Squibb Co. (NYSE:BMY) on 03/03/2023 declared a dividend of $ 0.5700 per share payable on May 01, 2023 to shareholders of record as of April 10, 2023.

Bristol Myers Squibb Co. (NYSE:BMY) has paid dividends since 1900, has a current dividend yield of 3.2952737808% and has increased its dividends for 13 successive years.

Bristol Myers Squibb Co.'s market cap is $ 145,214,311,440 and has a PE ratio of 23.45. The stock price closed yesterday at $ 69.19 and has a 52 week low/high of $ 65.95 and $ 81.43.

Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.

For more information on Bristol Myers Squibb Co. click here.